| (Values in U.S. Thousands) | Jun, 2021 | Jun, 2020 | Jun, 2019 | Jun, 2018 | Jun, 2017 |
| Sales | 1,090 | 419 | 332 | 271 | 448 |
| Sales Growth | +159.85% | +26.36% | +22.30% | -39.44% | unch |
| Net Income | -9,832 | -10,126 | -7,848 | -5,871 | -6,510 |
| Net Income Growth | +2.91% | -29.03% | -33.69% | +9.82% | unch |
Oventus Medical Ltd (OVN.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Oventus Medical Ltd is a medical device company. It is engaged in developing an oral appliance for the treatment of sleep apnoea and snoring. Its product includes O2Vent Optima . It offers oral appliance therapy, especially beneficial for the many people that suffer from nasal congestion, obstruction, and mouth breathing. The firm has two operating segments: Australia and North America.
Fiscal Year End Date: 06/30